Crystalline salts of 7-[4-(4-naphthalen-1-yl-piperazin-1-yl)- but oxy]-3,4-dihydro-1H-(1,8)naphthyridin-2 -one

Details for Australian Patent Application No. 2006310283 (hide)

Owner Pfizer Products Inc.

Inventors Beylin, Vladimir Genukk; Yahyai, Nahid

Agent Spruson & Ferguson

Pub. Number AU-A-2006310283

PCT Pub. Number WO2007/052104

Priority 60/731,919 31.10.05 US

Filing date 18 October 2006

Wipo publication date 10 May 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375 (2006.01)

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 April 2008 PCT application entered the National Phase

  PCT publication WO2007/052104 Priority application(s): WO2007/052104

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006310297-Aerosol composition and method

2006310265-Bacterial growth enhancer